A Study to Evaluate AMG 133 Administered Subcutaneously in Participants With Overweight or Obesity

Clinical trial NCT06976372 · COMPLETED

Trial details

NCT number: NCT06976372
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight Obesity

Start date: 2024-08-20
Primary completion: 2024-12-27
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.